(Reuters) – Voyager Therapeutics said on Tuesday Novartis would pay it $100 million upfront in cash as part of a licensing deal to develop gene therapy candidates.
(Reporting by Pratik Jain in Bengaluru; Editing by Shilpi Majumdar)
Novartis signs gene therapy deal with Voyager for $100 million upfront
Jan 2, 2024 | 7:16 AM
Current Weather
7-Day Forecast »
Terre Haute, IN, USA
48 °F Overcast
Now Playing
HI-99 | 99.9 FM | The Wabash Valley's Country Station
